Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children - A systematic review of prospective trials

Supportive Care in Cancer

Volumn 20, Issue 6, 2012, Pages 1135-1145

  Manji, A ^a   Beyene, J ^a,b,c   Dupuis, L L ^a,c   Phillips, R ^d   Lehrnbecher, T ^e   Sung, L ^a,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Cancer; Children; Febrile; Meta analysis; Neutropenia

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFEPIME; CEFIXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; GATIFLOXACIN; MEROPENEM; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; DEATH; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; HOSPITAL CARE; HUMAN; META ANALYSIS; MORTALITY; OUTPATIENT CARE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; CHILD; FEVER; HUMANS; NEOPLASMS; NEUTROPENIA; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84863985263     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1425-8     Document Type: Review

References (47)

1. Abbas AAH, Felimban SK, Cittana BA et al (2003) Once daily ceftriaxone and amikacin for outpatient treatment of neutropenic fever in children with acute lymphoblastic leukaemia. Haema 6 (4):501-506 (Pubitemid 37362691)
2. Ahmed N, El-Mahallawy HA, Ahmed IA, Nassif S, El-Beshlawy A, El-Haddad A (2007) Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: a randomized, prospective study. Pediatr Blood Cancer 49:786-792 (Pubitemid 47519513)
3. Ammann RA, Bodmer N, Hirt A et al (2010) Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol 28:2008-2014
4. Ammann RA, Simon A, de Bont ES (2005) Low risk episodes of fever and neutropenia in pediatric oncology: is outpatient oral antibiotic therapy the new gold standard of care? Pediatr Blood Cancer 45:244-247 (Pubitemid 41077156)
5. Aquino VM, Herrera L, Sandler ES, Buchanan GR (2000) Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer 88:1710-1714 (Pubitemid 30183158)
6. Bartolozzi S, Clerico A, Properzi E, Minori A, Castello MA (1997) Ceftriaxone as a single agent in empirical therapy of unexplained fever in granulocytopenic children with solid tumors. J Chemother 9:227-231 (Pubitemid 27288414)
7. Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328-340
8. Boragina M, Patel H, Reiter S, Dougherty G (2007) Management of febrile neutropenia in pediatric oncology patients: a Canadian survey. Pediatr Blood Cancer 48:521-526 (Pubitemid 46496346)
9. Cagol AR, Castro Junior CG, Martins MC et al (2009) Oral vs. intravenous empirical antimicrobial therapy in febrile neutropenic patients receiving childhood cancer chemotherapy. J Pediatr (Rio J) 85:531-535
10. Carstensen M, Sorensen JB (2008) Outpatient management of febrile neutropenia: time to revise the present treatment strategy. J Support Oncol 6:199-208 (Pubitemid 351836606)
11. Chamberlain JD, Smibert E, Skeen J, Alvaro F (2005) Prospective audit of treatment of paediatric febrile neutropenia in Australasia. J Paediatr Child Health 41:598-603 (Pubitemid 43961166)
12. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 (Pubitemid 17189972)
13. Duzova A, Kutluk T, Kanra G et al (2001) Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors. Turk J Pediatr 43:105-109 (Pubitemid 32537265)
14. El-Mahallawy HA, El-Wakil M, Moneer MM, Shalaby L (2011) Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer. Pediatr Blood Cancer 57:283-288
15. Freifeld A, Marchigiani D, Walsh T et al (1999) A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 341:305-311 (Pubitemid 29350300)
16. Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56-e93
17. Gupta A, Swaroop C, Agarwala S, Pandey RM, Bakhshi S (2009) Randomized controlled trial comparing oral amoxicillinclavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia. J Pediatr Hematol Oncol 31:635-641
18. Hayden JA, Cote P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144:427-437 (Pubitemid 46768164)
19. Higgins JPT, Green S, Cochrane Collaboration (2008) Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell, Chichester; Hoboken
20. Kamboj M, Sepkowitz KA (2009) Nosocomial infections in patients with cancer. Lancet Oncol 10:589-597
21. Kaplinsky C, Drucker M, Goshen J, Tamary H, Cohen IJ, Zaizov R (1994) Ambulatory treatment with ceftriaxone in febrile neutropenic children. Isr J Med Sci 30:649-651 (Pubitemid 24244968)
22. Kern WV, Cometta A, De Bock R, Langenaeken J, Paesmans M, Gaya H (1999) Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 341:312-318 (Pubitemid 29350301)
23. Klastersky J, Paesmans M, Rubenstein EB et al (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038-3051 (Pubitemid 30644129)
24. Kutluk T, Kurne O, Akyuz C et al (2004) Cefepime vs. meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours. Pediatr Blood Cancer 42:284-286 (Pubitemid 38235082)
25. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159-174 (Pubitemid 8054849)
26. Malik IA (1997) Out-patient management of febrile neutropenia in indigent paediatric patients. Ann Acad Med Singap 26:742-746 (Pubitemid 28069346)
27. Moher D, Pham B, Klassen TP et al (2000) What contributions do languages other than English make on the results of metaanalyses? J Clin Epidemiol 53:964-972
28. Mullen CA, Petropoulos D, Roberts WM et al (1999) Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer 86:126-134 (Pubitemid 29293385)
29. Mustafa MM, Aquino VM, Pappo A, Tkaczewski I, Buchanan GR (1996) A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia. J Pediatr 128:847-849 (Pubitemid 26181384)
30. Oude Nijhuis C, Kamps WA, Daenen SM et al (2005) Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol 23:7437-7444 (Pubitemid 46291805)
31. Paganini H, Gomez S, Ruvinsky S et al (2003) Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina. Cancer 97:1775-1780 (Pubitemid 36350721)
32. Paganini H, Rodriguez-Brieshcke T, Zubizarreta P et al (2001) Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. Cancer 91:1563-1567 (Pubitemid 32319269)
33. Petrilli A, Altruda Carlesse F, Alberto Pires Pereira C (2007) Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropenia. Pediatr Blood Cancer 49:682-686 (Pubitemid 350194435)
34. Petrilli AS, Dantas LS, Campos MC, Tanaka C, Ginani VC, Seber A (2000) Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. Med Pediatr Oncol 34:87-91 (Pubitemid 30090470)
35. Phillips B, Selwood K, Lane SM, Skinner R, Gibson F, Chisholm JC (2007) Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres. Arch Dis Child 92:495-498 (Pubitemid 46867264)
36. Phillips B, Wade R, Stewart LA, Sutton AJ (2010) Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people. Eur J Cancer 46:2950-2964
37. Pizzo PA (1993) Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328:1323-1332
38. Rondinelli PI, Ribeiro Kde C, de Camargo B (2006) A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol 28:665-670 (Pubitemid 44540164)
39. Santolaya ME, Alvarez AM, Aviles CL et al (2004) Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. J Clin Oncol 22:3784-3789 (Pubitemid 41095219)
40. Schimpff S, Satterlee W, Young VM, Serpick A (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 284:1061-1065
41. Shrestha PN, Sah KP, Rana R (2009) Emperical oral antibiotic therapy for children with low risk febrile neutropenia during cancer chemotherapy. J Nepal Paediatr Soc 29(1):22-25
42. Speyer E, Herbinet A, Vuillemin A, Chastagner P, Briancon S (2009) Agreement between children with cancer and their parents in reporting the child's health-related quality of life during a stay at the hospital and at home. Child Care Health Dev 35(4):489-495
43. Sung L, Feldman BM, Schwamborn G et al (2004) Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences. J Clin Oncol 22:3922-3929 (Pubitemid 41079874)
44. Teuffel O, Amir E, Alibhai SM, Beyene J, Sung L (2011) Costeffectiveness of outpatient management for febrile neutropenia in children with cancer. Pediatrics 127:e279-e286
45. Teuffel O, Ethier MC, Alibhai SM, Beyene J, Sung L (2011) Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis. Ann Oncol 11:2358-2365
46. Vidal L, Paul M, Ben-Dor I, Pokroy E, Soares-Weiser K, Leibovici L (2004) Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Cochrane Database Syst Rev: CD003992
47. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344-349 (Pubitemid 351289042)